The coronavirus disease (COVID-19) pandemic, which has spread around the world, caused
the death of many affected patients, partly because of the lack of oxygen arising from
impaired respiration or blood circulation. Thus, maintaining an appropriate level of
oxygen in the patients’ blood by devising alternatives to ventilator systems is a
top priority goal for clinicians. The present review highlights the ever-increasing
application of nanobubbles (NBs), miniature gaseous vesicles, for the oxygenation of
hypoxic patients. Oxygen-containing NBs can exert a range of beneficial physiologic and
pharmacologic effects that include tissue oxygenation, as well as tissue repair
mechanisms, antiinflammatory properties, and antibacterial activity. In this review, we
provide a comprehensive survey of the application of oxygen-containing NBs, with a
primary focus on the development of intravenous platforms. The multimodal functions of
oxygen-carrying NBs, including antimicrobial, antiinflammatory, drug carrying, and the
promotion of wound healing are discussed, including the benefits and challenges of using
NBs as a treatment for patients with acute hypoxemic respiratory failure, particularly
due to COVID-19.